Myrexis, Inc. (MYRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0080
+0.0010 (14.29%)
At close: Feb 10, 2025
Myrexis Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2005 |
|---|---|---|---|---|---|---|
Period Ending | Jun '13 Jun 30, 2013 | Jun '12 Jun 30, 2012 | Jun '11 Jun 30, 2011 | Jun '10 Jun 30, 2010 | Jun '09 Jun 30, 2009 | 2008 - 2005 |
| Operating Revenue | - | - | 0.19 | 0.09 | 5.46 | Upgrade
|
| Revenue | - | - | 0.19 | 0.09 | 5.46 | Upgrade
|
| Revenue Growth (YoY) | - | - | 105.56% | -98.35% | -95.07% | Upgrade
|
| Cost of Revenue | - | - | 0.71 | 1.15 | 2.01 | Upgrade
|
| Gross Profit | - | - | -0.53 | -1.06 | 3.44 | Upgrade
|
| Selling, General & Admin | 10.74 | 14.74 | 16.73 | 21.06 | 8.98 | Upgrade
|
| Research & Development | 0.45 | 11.08 | 21.58 | 27.08 | 52.6 | Upgrade
|
| Operating Expenses | 11.19 | 25.82 | 38.31 | 48.14 | 61.58 | Upgrade
|
| Operating Income | -11.19 | -25.82 | -38.84 | -49.19 | -58.14 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.32 | 0.54 | 1.32 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -11.12 | -25.5 | -38.3 | -47.87 | -58.14 | Upgrade
|
| Merger & Restructuring Charges | -0.8 | -5.98 | -0.5 | 1.3 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | 0 | 0.01 | 0.04 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.29 | 0.27 | - | -0.2 | - | Upgrade
|
| Asset Writedown | - | - | -1.11 | -0.22 | - | Upgrade
|
| Other Unusual Items | - | - | 1.2 | - | - | Upgrade
|
| Pretax Income | -11.62 | -31.21 | -38.71 | -46.95 | -58.14 | Upgrade
|
| Net Income | -11.62 | -31.21 | -38.71 | -46.95 | -58.14 | Upgrade
|
| Net Income to Common | -11.62 | -31.21 | -38.71 | -46.95 | -58.14 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 26 | 26 | 25 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 26 | 26 | 25 | 24 | Upgrade
|
| Shares Change (YoY) | 11.83% | 3.43% | 3.94% | 2.38% | - | Upgrade
|
| EPS (Basic) | -0.39 | -1.18 | -1.52 | -1.91 | -2.42 | Upgrade
|
| EPS (Diluted) | -0.39 | -1.18 | -1.52 | -1.91 | -2.42 | Upgrade
|
| Free Cash Flow | -12.97 | -27.83 | -33.55 | -42.5 | -61.06 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -1.05 | -1.31 | -1.73 | -2.55 | Upgrade
|
| Gross Margin | - | - | -284.86% | - | 63.09% | Upgrade
|
| Operating Margin | - | - | -20993.51% | -54657.78% | -1065.54% | Upgrade
|
| Profit Margin | - | - | -20923.24% | -52167.78% | -1065.54% | Upgrade
|
| Free Cash Flow Margin | - | - | -18134.05% | -47225.56% | -1119.08% | Upgrade
|
| EBITDA | -10.81 | -24.54 | -37.18 | -47.85 | -55.28 | Upgrade
|
| D&A For EBITDA | 0.39 | 1.28 | 1.66 | 1.35 | 2.85 | Upgrade
|
| EBIT | -11.19 | -25.82 | -38.84 | -49.19 | -58.14 | Upgrade
|
| Revenue as Reported | - | - | 0.19 | 0.09 | 5.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.